2015 Conference Schedule, Speaker Line-up, and Registration Now Available!

The 6th annual IMMH Conference will be held September 17-20, 2015 in San Diego at the beautiful Hyatt Regency Mission Bay Spa and Marina! 


The conference has been growing every year, and this year, we're excited to announce that we're expanding from three days to four days, including lunches, offering morning yoga sessions, and so much more! 


The full conference schedule, speaker line-up, and pricing/registration information is on the web site now!  Go to www.IMMH2015.com to see all the conference information, to register, or to become an exhibitor or sponsor. 


We'll see you in San Diego!



   IMMH 2015 Speaker Spotlight: 


   Daniel Amen, M.D.




Daniel Amen is dedicated to optimizing and healing the brain.  He is a physician, double board certified psychiatrist, nine-time NY Times bestselling author, and a PBS TV host and producer.  He is the Founder of Amen Clinics in Costa Mesa and San Francisco, CA, Bellevue, WA, Reston, VA, Atlanta, GA and New York, NY.  The clinics have the world's largest psychiatric database of functional brain scans, totaling nearly 100,000 scans on patients from 111 countries.  Dr. Amen is the lead researcher on the largest brain imaging and rehabilitation study on NFL players and he is the co-creator of The Daniel Plan with Rick Warren and Mark Hyman, a program to get the world healthy through religious organizations.  To read more about SPECT brain imaging and the impact it can have on mental health, read this except from Dr. Amen's blog post, "Brain Disorder May be Visible 10 Years Before Behavioral Changes Occur":


Brain Disorders and Early Detection

When it comes to brain disorders such as Schizophrenia, Bipoar Disorder, Depression, PTSD, Anxiety Disorders, Eating Disorders, ADHD, OCD, Borderline Personality and Alzheimer's, most medical doctors are still waiting for symptoms to manifest before doing anything about it. Think about if we still waited for the 'heart attack' to address heart disease? We would lose over a million people a year unnecessarily. There are often changes in the brain a decade or more before there are visible changes to behavior. Many scientists believe that Alzheimer's disease actually starts 30 years before people have any symptoms!


Brain Disorders vs. Behavioral Disorders

Dr. Insel says to the medical community, "Its time that we make a conceptual transformation regarding how we look at these disorders to best achieve early intervention. We have been referring to these disorders as behavior disorders. Whatwe need to make progress is to re-think these disorders as Brain Disorders… and for these disorders, behavior is the last thing to change."


Brain Disorders Left Undiagnosed:

Once behavior does change due to a brain disorder, leading a normal, happy life can become very difficult. Dr. Insel estimates that:

·         1 in 5 people will suffer from a mental disorder in their lifetime.

·         1 in 20 people with a mental disorder will become truly disabled by it.

·         30% of disability from medical causes can be attributed to mental disorders.



Click here to read full article.




IMMH 2015 Speaker Spotlight: 


James Greenblatt, M.D.



Dr. Greenblatt has treated patients with mood disorders and complex eating disorders since 1990.  An acknowledged integrative medicine expert, Dr. Greenblatt has lectured throughout the United States on the scientific evidence for nutritional interventions in psychiatry and mental illness.  His books, Answers to Anorexia, The Breakthrough Depression Solution, and Answers to Appetite Control draw on his many years of experience and expertise in integrative medicine while treating patients with eating and mood disorders.  Dr. Greenblatt currently serves as the Chief Medical Officer at Walden Behavioral Care in Waltham, MA and serves as an Assistant Clinical Professor of Psychiatry at Tufts University School of Medicine. He is also the Founder and Medical Director of Comprehensive Psychiatric Resources, a private psychiatric practice focused on utilizing integrative medicine.


The following information is taken from an article by Dr. Greenblatt about the connection between inflammation and mood disorder, "The Brain on Fire:  Inflammation and Depression":


We have all had the flu or at least know what it feels like.  The miserable collection of symptoms includes lack of energy, difficulty concentrating, sleepiness, loss of appetite, and general malaise.  For most of us these symptoms disappear within a few days. For some, it takes much longer. Although we tend to blame the influenza virus for making us feel miserable, the symptoms are actually a result of our immune system trying to combat the virus.  The symptoms of the flu are brought on by proteins, pro-inflammatory cytokines, our bodies produce in order to fight the flu and other infections.


When the immune system is under attack from physical injury, infections, or toxins, the immune system generates an inflammatory response. Inflammation is a normal physiological process that is now understood to play a major role in many chronic medical illnesses, including cancer, heart disease, diabetes, asthma, and obesity. In each of these cases inflammation causes the release of cytokines. Cytokines, which come in many different classes, including anti- and pro-inflammatory, behave as messengers and signal cells of the immune system.  The effects of pro-inflammatory cytokines can cause a diverse array of physical and psychological symptoms. When this happens it is referred to as sickness behavior.  Recently, scientists have been able to demonstrate how the symptoms of sickness behavior mirror those of depression. Researchers and health professionals are now beginning to understand the connection between inflammation and depression.



Click here to read full article. 




IMMH 2015 Speaker Spotlight:


Andrea Gruszecki, N.D.



Andrea Gruszecki received her Doctorate in Naturopathy from Southwest College of Naturopathic Medicine.  She has worked in conventional medical settings as a radiologic technologist and Army medic, and spent 13 years in private practice.  Through her patients, Dr Gruszecki learned how stress responses created obstacles to health.

Dr. Gruszecki serves as a consultant for the Scientific Support Department of Doctor's Data, writing, researching and presenting interpretations and information on a variety of health-related subjects.  She has reviewed thousands of stool analysis result reports with clinicians, and is often able to provide insight for practitioners even on seemingly "normal" stool test results.


To gain more insight into Dr. Gruszecki's work at Doctor's Data, read this excerpt from a recent piece she wrote, "Functional Assessment of Urinary Neurotransmitters":


Evaluation of the gastrointestinal microbiome should be considered an essential part of any patient evaluation for mood, behavior or psychiatric disorders.  Animal studies have demonstrated the effects of acute and chronic stress on the gastrointestinal system, and the effects of gut microflora disruptions.  Stress or disrupted neurotransmitter signaling in the gut may induce changes in immune functions, inflammatory pathways and microbiome populations.  A loss of diversity (loss of populations) of expected and beneficial species groups and altered neurotransmitter levels may disrupt digestion, motility, immunity, permeability and absorption of nutrients


The gastrointestinal tract (GIT) has its own nervous system.  The enteric nervous system is sometimes call a "second brain"; fibers from the GIT travel directly to the central nervous system via the vagus nerve.  Ninety percent of the fibers in the vagus nerve originate in the gut and travel to the brain.  Altered neurotransmitter levels may contribute to autonomic enteric nervous system disorders in the GIT.   In addition to GIT-specific neuro-active compounds, the gastrointestinal tract responds to signals from catecholamines (dopamine, epinephrine, norepinephrine), serotonin and melatonin.  Mood disorders may alter the levels of gastrointestinal hormones, such as somatostatin and vasoactive intestinal peptide (VIP).  Alterations in GIT hormone signaling may contribute to irritable bowel syndrome (IBS).


  Click here to read full article.



Facebook Link     Twitter Link     Pinterest Link


Forward to a Friend

Upcoming Events



Upcoming Free


Integrative Medicine is Personalized Medicine


Presented by James Greenblatt, M.D. at 6 p.m. PST on Mar. 24


The current treatment model in psychiatry relies solely upon symptom-based recommendations for medication with little consideration for the biochemical individuality or the underlying biological mechanisms that may be contributing or causing symptoms. This webinar will present an overview of integrative medicine for mental health with a focus on mood disorders. A review of current research supporting the relationship between nutritional deficiencies and depression will be presented in addition to clinical case studies.


Click here for more information and to register for this webinar.


Small Intestine Bacterial Overgrowth (SIBO) – Causes, Treatments, and Using the Organic Acids Tests as a Diagnostic Tool


Presented by Kurt Woeller, D.O. at 6 p.m. PST on April 1


SIBO is a bowel disorder that manifests as bloating, abdominal distension, abdominal pain, excessive gas production and often times constipation and/or diarrhea. It is caused by abnormal amounts of bacteria in the small intestine often brought about by poor digestion and poor peristaltic activity causing a situation where high amounts of large intestine bacteria find their way into the small intestine. There are a number of treatments for SIBO, as well as tests, with one being the Organic Acids Test which can provide indicators of SIBO.


Click here for more information and to register for this webinar.


To view a list of previously recorded webinars and other videos click here.


Featured Products


CDP Choline


Cytidine Diphosphate Choline (CDP Choline) is an active lipotrope of choline that restores brain levels of Phosphatidylserine, Phosphatidylcholine and Sphingomyelin which are crucial to the function of neurons and the myelin sheath that protects them. It also increases brain levels of key neurotransmitters like acetylcholine (for memory), dopamine (for fine motor control and mood), and norepinephrine (for mental energy).



CDP Choline has also been shown to inhibit the ability of Phospholipase A2 (PLA2) to promote inflammation in the body.  With all of the above modulating activities, it isn't surprising that CDP Choline has so many beneficial effects on the brain and body, helping to maintain optimal function and balance.


Click here for more information


Save 20% off your order of CDP Choline, now through March 31!  Use promo code CDPC20%. 




*Offer good only for retail purchases through March 31, 2015.



The Great Plains Laboratory is now the only commercial lab to offer a Phopholipase A2 (PLA2) Activity Test in urine, which can easily be added to any Organic Acids Test.  For more information about PLA2 and inflammatory disorders, including depression and neurodegenerative diseases, go to http://www.greatplainslaboratory.com/home/eng/pla2.asp



  IMMH 2014 Conference DVD



Don't forget that the IMMH 2014 Conference DVD is  available.  If you haven't reserved your copy, you may do that here:


Click Here to Purchase!


The 2014 conference DVD has some great new features, including the ability to download a PDF of the PowerPoint slides from each presentation, right from where you're viewing them! 


Get your copy now, while supplies last! 



New Book Available



If you're looking for a book that can help introduce your patients and patients' families to a non-intimidating overview of biomedical interventions to improve their mental health, you might want to check out David Moyer's, 10 Ways to Keep Your Brain from Screaming "Ouch!". 


For more information about this book and its author, go to www.beyondmentalillness.us or www.amazon.com. 


Stand Up for Mental Health



You are receiving this message because you subscribed via our website or at a conference.

If you no longer wish to receive updates from IMMH, unsubscribe here.


NOTE: Please do not reply to this e-mail. This is an unmonitored mailbox.